TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Sullivan John F | VP of Quality & Engineering | Apr 07 | Option Exercise | 5.00 | 15,000 | 74,940 | 25,828 | Apr 09 07:38 PM | Sullivan John F | VP of Quality & Engineering | Apr 07 | Sale | 36.83 | 15,000 | 552,394 | 10,828 | Apr 09 07:38 PM | Carey John F | VP of Operations | Apr 05 | Option Exercise | 16.14 | 3,360 | 54,230 | 3,360 | Apr 07 06:34 PM | Hassanein Waleed H | President & CEO | Apr 05 | Option Exercise | 0.28 | 125,000 | 35,000 | 403,843 | Apr 07 06:35 PM | Carey John F | VP of Operations | Apr 05 | Sale | 36.87 | 3,360 | 123,883 | 0 | Apr 07 06:34 PM | Hassanein Waleed H | President & CEO | Apr 01 | Sale | 40.63 | 60,000 | 2,437,871 | 278,843 | Apr 05 06:17 PM | Gordon Stephen | Chief Financial Officer | Mar 15 | Option Exercise | 0.67 | 10,000 | 6,700 | 10,000 | Mar 16 06:14 PM | Gordon Stephen | Chief Financial Officer | Mar 15 | Sale | 39.81 | 10,000 | 398,100 | 0 | Mar 16 06:14 PM | Carey John F | VP of Operations | Mar 11 | Sale | 37.50 | 3,200 | 120,000 | 0 | Mar 11 09:19 PM | Hassanein Waleed H | President & CEO | Mar 10 | Option Exercise | 2.21 | 35,007 | 77,365 | 373,850 | Mar 11 09:17 PM | Hassanein Waleed H | President & CEO | Mar 10 | Sale | 33.79 | 35,007 | 1,182,963 | 338,843 | Mar 11 09:17 PM | Khayal Tamer I | Chief Commercial Officer | Mar 08 | Option Exercise | 0.28 | 20,000 | 5,600 | 66,076 | Mar 09 05:36 PM | Khayal Tamer I | Chief Commercial Officer | Mar 08 | Sale | 32.00 | 20,000 | 640,000 | 46,076 | Mar 09 05:36 PM | Khayal Tamer I | Chief Commercial Officer | Mar 05 | Option Exercise | 0.36 | 20,000 | 7,200 | 66,076 | Mar 09 05:36 PM | Khayal Tamer I | Chief Commercial Officer | Mar 05 | Sale | 30.90 | 20,000 | 618,099 | 46,076 | Mar 09 05:36 PM | Gordon Stephen | Chief Financial Officer | Feb 16 | Option Exercise | 0.67 | 10,000 | 6,700 | 10,000 | Feb 17 05:43 PM | Gordon Stephen | Chief Financial Officer | Feb 16 | Sale | 31.33 | 10,000 | 313,300 | 0 | Feb 17 05:43 PM | Sullivan John F | VP of Quality & Engineering | Feb 09 | Option Exercise | 0.28 | 8,600 | 2,408 | 19,428 | Feb 11 08:57 AM | ABRAMS CAPITAL MANAGEMENT, L.P | 10% Owner | Feb 09 | Sale | 33.32 | 786,664 | 26,208,734 | 2,624,712 | Feb 10 04:53 PM | TOBIN JAMES R | Director | Feb 09 | Sale | 32.83 | 10,168 | 333,786 | 424,637 | Feb 10 06:59 PM | Sullivan John F | VP of Quality & Engineering | Feb 09 | Sale | 32.81 | 8,600 | 282,188 | 10,828 | Feb 11 08:57 AM | Gordon Stephen | Chief Financial Officer | Feb 08 | Option Exercise | 0.67 | 1,429 | 957 | 1,429 | Feb 10 07:00 PM | Gordon Stephen | Chief Financial Officer | Feb 08 | Sale | 25.01 | 10,000 | 250,100 | 0 | Feb 10 07:00 PM | ABRAMS CAPITAL MANAGEMENT, L.P | 10% Owner | Feb 08 | Sale | 26.24 | 88,483 | 2,321,705 | 3,411,376 | Feb 10 04:53 PM | Sullivan John F | VP of Quality & Engineering | Jan 19 | Option Exercise | 0.39 | 9,617 | 3,751 | 20,445 | Jan 20 09:00 PM | Sullivan John F | VP of Quality & Engineering | Jan 19 | Sale | 22.12 | 9,617 | 212,728 | 10,828 | Jan 20 09:00 PM | Hassanein Waleed H | President & CEO | Jan 05 | Option Exercise | 0.39 | 123,414 | 48,131 | 338,843 | Jan 14 06:56 PM | Gordon Stephen | Chief Financial Officer | Jan 04 | Sale | 20.00 | 1,184 | 23,680 | 8,371 | Jan 05 06:04 PM | Gordon Stephen | Chief Financial Officer | Dec 31 | Sale | 20.00 | 8,816 | 176,320 | 9,755 | Jan 05 06:04 PM | Sullivan John F | VP of Quality & Engineering | Dec 21 | Sale | 17.99 | 1,000 | 17,990 | 10,828 | Dec 22 04:19 PM | Sullivan John F | VP of Quality & Engineering | Dec 16 | Option Exercise | 0.39 | 1,000 | 390 | 11,828 | Dec 17 05:57 PM | Sullivan John F | VP of Quality & Engineering | Dec 15 | Option Exercise | 0.39 | 3,000 | 1,170 | 13,828 | Dec 17 05:57 PM | Sullivan John F | VP of Quality & Engineering | Dec 15 | Sale | 16.63 | 3,000 | 49,890 | 10,828 | Dec 17 05:57 PM | Provost Miriam | VP of US Regulatory & FDA Rel. | Dec 11 | Option Exercise | 3.22 | 4,600 | 14,812 | 4,600 | Dec 14 04:53 PM | Carey John F | VP of Operations | Sep 01 | Option Exercise | 0.39 | 2,000 | 780 | 5,200 | Sep 03 06:41 PM | Carey John F | VP of Operations | Sep 01 | Sale | 17.59 | 2,000 | 35,180 | 3,200 | Sep 03 06:41 PM | Carey John F | VP of Operations | Aug 03 | Option Exercise | 2.21 | 2,000 | 4,420 | 5,200 | Aug 05 08:08 PM | Carey John F | VP of Operations | Aug 03 | Sale | 18.61 | 2,000 | 37,214 | 3,200 | Aug 05 08:08 PM | Carey John F | VP of Operations | Jul 01 | Option Exercise | 1.40 | 2,000 | 2,793 | 5,200 | Jul 02 07:42 PM | Carey John F | VP of Operations | Jul 01 | Sale | 17.09 | 2,000 | 34,174 | 3,200 | Jul 02 07:42 PM | Carey John F | VP of Operations | Jun 01 | Option Exercise | 0.39 | 2,000 | 780 | 5,200 | Jun 02 06:10 PM | Carey John F | VP of Operations | Jun 01 | Sale | 13.21 | 2,000 | 26,420 | 3,200 | Jun 02 06:10 PM | Carey John F | VP of Operations | May 01 | Option Exercise | 0.39 | 2,000 | 780 | 5,200 | May 04 06:04 PM | Carey John F | VP of Operations | May 01 | Sale | 17.05 | 2,000 | 34,105 | 3,200 | May 04 06:04 PM | Gordon Stephen | Chief Financial Officer | Apr 27 | Sale | 18.00 | 9,900 | 178,200 | 18,571 | Apr 29 04:22 PM | Gordon Stephen | Chief Financial Officer | Apr 22 | Sale | 18.00 | 100 | 1,800 | 28,471 | Apr 24 05:54 PM |
|